Physician profile
Robert Couch
NPI 1659342574
$1,289.31
in general payments reported to CMS, 2019-2025
14 companies · $218 in 2025
The $218 reported for 2025 was more than what 76% of Pediatrics providers received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $311 · 2020: $36.81 · 2021: $141 · 2022: $107 · 2023: $168 · 2024: $308 · 2025: $218.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $694.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $694.09 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Supernus Pharmaceuticals, INC. | $381.08 | 2022-2025 | Qelbree, Qelbree |
| Corium, LLC | $228.11 | 2022-2025 | Azstarys |
| Novartis Pharmaceuticals Corporation | $151.21 | 2019 | |
| Regeneron Healthcare Solutions, INC. | $123.31 | 2019-2022 | |
| Ironshore Pharmaceuticals INC. | $83.78 | 2019-2024 | Jornay Pm |
| Glaxosmithkline, LLC. | $82.66 | 2020-2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $60.74 | 2021 | |
| Pfizer INC. | $55.16 | 2022-2023 | |
| Genzyme Corporation | $41.03 | 2019 | |
| Collegium Pharmaceutical, INC. | $21.80 | 2025 | Jornay Pm |
| Arbor Pharmaceuticals, INC. | $16.15 | 2019 | |
| Csl Behring | $15.49 | 2021 | |
| Kaleo, INC. | $15.44 | 2019 | |
| Kowa Pharmaceuticals America, INC. | $13.35 | 2024 | Zoryve |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Couch listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.